-
A guide to understanding adenovirus, the diseases it causes and the best ways to treat these conditions.
(20 Mar 2010 03:32)
... Adenoviruses are non-enveloped, double-stranded-DNA viruses with icosahedral capsids. ... are the agents of gastroenteritis. Distinguishing between adenoviral and bacterial conjunctivitis can be achieved via ...
-
Life Sciences: New research on life sciences from Keimyung University, Department of Internal Medicine summarized
(20 Mar 2010 04:23)
... 8-bromoadenosine-cAMP-treated cells. In a transient study, ATF6 inhibited the PEPCK and G6Pase promoters. Also, adenovirus-mediated overexpression of ATF6 in H4IIE cells decreased forskolin-stimulated PEPCK and G6Pase ATF6 expression by ...
-
Booster shot 'improves tuberculosis resistance in previously vaccinated adults
(17 Mar 2010 16:33)
... This study is the first to report results from testing an adenovirus-35-based vaccine in humans. "The world urgently needs new, better vaccines against TB. It is ...
-
Booster shot improves TB resistance
(17 Mar 2010 18:55)
... in South Africa. This study is the first to report results from testing an adenovirus-35-based vaccine in humans. "The world urgently needs new, better vaccines against TB. It is ...
-
New TB booster shows promise
(16 Mar 2010 18:18)
... World Health Organization. This study is the first to report results from testing an adenovirus-35-based vaccine in humans. Adenovirus-35 is attractive to vaccine developers because fewer humans have been ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Evaluation of continuous low dose rate versus acute single high dose rate radiation combined with oncolytic viral therapy for prostate cancer
(16 Mar 2010 07:09)
... Medicine, 600 N. Wolfe Street, Marburg Room 205A, Baltimore, MD 21287-2101, USA. Conditionally Replicative Adenovirus (CRAd) has been previously demonstrated to augment the activity of radiation, resulting in synergy ...
-
Booster shot appears to improve TB resistance in previously vaccinated adults
(17 Mar 2010 06:37)
... World Health Organization. This study is the first to report results from testing an adenovirus-35-based developers because fewer humans have been exposed to this strain of the , and ...
-
GenVec Is Not Just a One Trick Pony
(15 Mar 2010 21:25)
... with GenVec., which will support the generation of HIV vaccine candidates with GenVec's alternate adenovirus serotype technology. Phase 1 SBIR grant from the National Cancer Institute [NCI] of the ...
-
Simple blood test identifies coeliac
(18 Mar 2010 03:30)
... We didnt think too much of it, she said. The following week Lilli had adenovirus that Kylie said resulted Lilli having little energy and losing weight. She was sick ...
-
It's Time to Reassess Where We Stand With an HIV Vaccine As Numbers Infected Rise in UN Study
(16 Mar 2010 22:13)
... Inc., prior to joining GeoVax. At PaxVax, he led research and preclinical development of Adenovirus vectored vaccine candidates. During his professional life he has worked on the development of ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Vivante GMP Solutions Completes Successful QP Audit of GMP Facility and Quality Systems
(12 Mar 2010 04:42)
... through a predecessor company, Vivante created the adenoviral reference material (ARM) that serves as the ... gold standard against which all other U.S. adenovirus-based materials are compared. Vivante was created in ...
-
Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytom
(12 Mar 2010 17:16)
... viremia. Participants will also be monitored for other dsDNA viruses susceptible to CMX001, including adenovirus, BK virus, and Epstein Barr virus. Safety assessments will be conducted throughout the study. ...
-
GenVec Reports Fourth Quarter and 2009 Year-End Financial Results
(12 Mar 2010 20:24)
... fourth year, which will support the generation of HIV vaccine candidates with GenVec's alternate adenovirus serotype technology. -- We received a Phase 1 SBIR grant from the National Cancer ...